IL9 and asthma: Unfortunately, however, a randomized controlled trial involving over 300 asthma patients did not find any beneficial improvement in asthma symptoms and lung function compared with the placebo group in patients treated with MEDI-528, a humanized IgG1 monoclonal antibody that inhibits the function of IL-9 [54].